CD14(+) macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?

por Heeren, A Marijne, Kenter, Gemma G, Jordanova, Ekaterina S, de Gruijl, Tanja D
Publicado no Oncoimmunology (2015)

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

por Mehta, Akash M., Jordanova, Ekaterina S., Kenter, Gemma G., Ferrone, Soldano, Fleuren, Gert- Jan
Publicado em 2007

Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer

por Rutten, Marianne J, Leeflang, Mariska MG, Kenter, Gemma G, Mol, Ben Willem J, Buist, Marrije
Publicado no Cochrane Database Syst Rev (2014)

Cervical cancer survivors’ and partners’ experiences with sexual dysfunction and psychosexual support

por Vermeer, Willemijn M., Bakker, Rinske M., Kenter, Gemma G., Stiggelbout, Anne M., ter Kuile, Moniek M.
Publicado no Support Care Cancer (2015)

Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival

por Ferns, Debbie M, Kema, Ido P, Buist, Marrije R, Nijman, Hans W, Kenter, Gemma G, Jordanova, Ekaterina S
Publicado no Oncoimmunology (2015)

Rationale and study protocol of the Physical Activity and Dietary intervention in women with OVArian cancer (PADOVA) study: a randomised controlled trial to evaluate effectiveness...

por Stelten, Stephanie, Hoedjes, Meeke, Kenter, Gemma G, Kampman, Ellen, Huijsmans, Rosalie J, van Lonkhuijzen, Luc RCW, Buffart, LM
Publicado no BMJ Open (2020)

Supravaginal hysterectomy in Curaçao prevalence and impact on screening for cervical cancer

por Hooi, Desiree J., Meijer, Chris J.L.M., Witte, Birgit I., Bravio, Igor Gomes, Pinedo, Herbert M., Kenter, Gemma G.
Publicado no Prev Med Rep (2017)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer

por Rutten, Marianne J., Sonke, Gabe S., Westermann, Anneke M., van Driel, Willemien J., Trum, Johannes W., Kenter, Gemma G., Buist, Marrije R.
Publicado no Obstet Gynecol Int (2015)

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases

por Ferns, Debbie M., Heeren, A. Marijne, Samuels, Sanne, Bleeker, Maaike C. G., de Gruijl, Tanja D., Kenter, Gemma G., Jordanova, Ekaterina S.
Publicado no J Immunother Cancer (2016)

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer

por Kloth, Judith N, Oosting, Jan, van Wezel, Tom, Szuhai, Karoly, Knijnenburg, Jeroen, Gorter, Arko, Kenter, Gemma G, Fleuren, Gert Jan, Jordanova, Ekaterina S
Publicado em 2007

Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer

por van de Vrie, Roelien, Rutten, Marianne J, Asseler, Joyce Danielle, Leeflang, Mariska MG, Kenter, Gemma G, Mol, Ben Willem J, Buist, Marrije
Publicado no Cochrane Database Syst Rev (2019)

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix

por Heeren, A Marijne, Punt, Simone, Bleeker, Maaike CG, Gaarenstroom, Katja N, van der Velden, Jacobus, Kenter, Gemma G, de Gruijl, Tanja D, Jordanova, Ekaterina S
Publicado no Mod Pathol (2016)

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine

por Hooi, Desiree J, Lissenberg-Witte, Birgit I, de Koning, Maurits N C, Pinedo, Herbert M, Kenter, Gemma G, Meijer, Chris JLM, Quint, Wim G
Publicado no Sex Transm Infect (2018)

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass

por Wegdam, Wouter, Moerland, Perry D, Meijer, Danielle, de Jong, Shreyas M, Hoefsloot, Huub C J, Kenter, Gemma G, Buist, Marrije R, Aerts, Johannes MF G
Publicado em 2012

Label-Free LC-MS(e) in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors

por Wegdam, Wouter, Argmann, Carmen A., Kramer, Gertjan, Vissers, Johannes P., Buist, Marrije R., Kenter, Gemma G., Aerts, Johannes M. F. G., Meijer, Danielle, Moerland, Perry D.
Publicado em 2014

Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area

por Heeren, A. Marijne, de Boer, Eline, Bleeker, Maaike C.G., Musters, René J.P., Buist, Marrije R., Kenter, Gemma G., de Gruijl, Tanja D., Jordanova, Ekaterina S.
Publicado no Oncotarget (2015)

Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study

por Kremer, Wieke W, Berkhof, Johannes, Bleeker, Maaike CG, Heideman, Daniëlle AM, van Trommel, Nienke E, van Baal, Marchien W, Verhoeve, Harold R, Meijer, Chris JLM, Kenter, Gemma G
Publicado no BMJ Open (2019)

Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer

por Heeren, A. Marijne, van Luijk, Iske F., Lakeman, Joost, Pocorni, Noëlle, Kole, Jeroen, de Menezes, Renée X., Kenter, Gemma G., Bosse, Tjalling, de Kroon, Cornelis D., Jordanova, Ekaterina S.
Publicado no Cancer Immunol Immunother (2019)

Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review

por van Baal, Juliette O. A. M., van Noorden, Cornelis J. F., Nieuwland, Rienk, Van de Vijver, Koen K., Sturk, Auguste, van Driel, Willemien J., Kenter, Gemma G., Lok, Christianne A. R.
Publicado no J Histochem Cytochem (2017)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status

por Veluchamy, John P., Heeren, A. Marijne, Spanholtz, Jan, van Eendenburg, Jaap D. H., Heideman, Daniëlle A. M., Kenter, Gemma G., Verheul, Henk M., van der Vliet, Hans J., Jordanova, Ekaterina S., de Gruijl, Tanja D.
Publicado no Cancer Immunol Immunother (2016)